https://pipelinereview.com/in8bio-provides-update-from-the-ongoing-phase-1-clinical-trial-of-its-allogeneic-gamma-delta-t-cell-therapy-in-leukemia-patients-undergoing-hematopoietic-stem-cell-transplant/